Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ReposiTrak (TRAK) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for ReposiTrak (TRAK) over the last 15 years, with Q3 2025 value amounting to $2.0 million.

  • ReposiTrak's Accumulated Expenses rose 5437.49% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 5437.49%. This contributed to the annual value of $1.8 million for FY2025, which is 1846.34% up from last year.
  • Latest data reveals that ReposiTrak reported Accumulated Expenses of $2.0 million as of Q3 2025, which was up 5437.49% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, ReposiTrak's Accumulated Expenses registered a high of $2.0 million during Q3 2025, and its lowest value of $738283.0 during Q3 2021.
  • Over the past 5 years, ReposiTrak's median Accumulated Expenses value was $1.4 million (recorded in 2024), while the average stood at $1.4 million.
  • Per our database at Business Quant, ReposiTrak's Accumulated Expenses tumbled by 5688.46% in 2021 and then surged by 9767.99% in 2022.
  • Over the past 5 years, ReposiTrak's Accumulated Expenses (Quarter) stood at $1.1 million in 2021, then increased by 23.88% to $1.3 million in 2022, then increased by 22.65% to $1.6 million in 2023, then fell by 13.3% to $1.4 million in 2024, then soared by 40.16% to $2.0 million in 2025.
  • Its Accumulated Expenses stands at $2.0 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.2 million for Q1 2025.